Larimar Therapeutics Inc
NASDAQ:LRMR

Watchlist Manager
Larimar Therapeutics Inc Logo
Larimar Therapeutics Inc
NASDAQ:LRMR
Watchlist
Price: 3.97 USD 1.53%
Market Cap: 339.8m USD

Wall Street
Price Targets

LRMR Price Targets Summary
Larimar Therapeutics Inc

Wall Street analysts forecast LRMR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LRMR is 16.97 USD with a low forecast of 7.07 USD and a high forecast of 27.3 USD.

Lowest
Price Target
7.07 USD
78% Upside
Average
Price Target
16.97 USD
327% Upside
Highest
Price Target
27.3 USD
588% Upside
Larimar Therapeutics Inc Competitors:
Price Targets
ARGX
argenx SE
16% Upside
VITR
Vitrolife AB
38% Upside
005690
Pharmicell Co Ltd
13% Upside
251120
Bio-FD&C Co Ltd
22% Upside
CGON
CG Oncology Inc
82% Upside
PGEN
Precigen Inc
107% Upside
KURA
Kura Oncology Inc
204% Upside
LCTX
Lineage Cell Therapeutics Inc
169% Upside

Revenue
Forecast

Revenue Estimate
Larimar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Larimar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Larimar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LRMR's stock price target?
Price Target
16.97 USD

According to Wall Street analysts, the average 1-year price target for LRMR is 16.97 USD with a low forecast of 7.07 USD and a high forecast of 27.3 USD.

Back to Top